Among these, the type 2 segment dominated the market with the largest market share in 2023 and is anticipated to witness a significant CAGR growth during the forecast period
Using bulk RNA-sequencing data, we found that lower expression of mevalonate decarboxylase ( MVD ), mevalonate kinase ( MVK ), farnesyl diphosphate synthase ( FDPS ), and farnesyl diphosphate farnesyltransferase 1 ( FDFT1 ) was independently associated with improved survival (Figure 1CD)
Novo, currently Lillys chief rival in the space, struck a deal with the Danish firm Ascendis for a once-monthly GLP-1 drug in November
Ivim has been featured in the New York Times, Forbes, TIME, and CNN, and is positioned as one of the more clinically engaged telehealth GLP-1 platforms for another Ivim head-to-head, see our Ivim vs Henry Meds comparison
J Appl Biobehav Res
& Quaade, F